NO901710L - Syre-resistent fgf-sammensetning og fremgangsmaate for behandling av saardannende sykdommer i mave-tarm kanalen. - Google Patents

Syre-resistent fgf-sammensetning og fremgangsmaate for behandling av saardannende sykdommer i mave-tarm kanalen.

Info

Publication number
NO901710L
NO901710L NO90901710A NO901710A NO901710L NO 901710 L NO901710 L NO 901710L NO 90901710 A NO90901710 A NO 90901710A NO 901710 A NO901710 A NO 901710A NO 901710 L NO901710 L NO 901710L
Authority
NO
Norway
Prior art keywords
acid
resistant
treatment
mave
phgf
Prior art date
Application number
NO90901710A
Other languages
English (en)
Other versions
NO901710D0 (no
Inventor
Moses J Folkman
Kato Koichi
Original Assignee
Childrens Medical Center
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center, Takeda Chemical Industries Ltd filed Critical Childrens Medical Center
Publication of NO901710L publication Critical patent/NO901710L/no
Publication of NO901710D0 publication Critical patent/NO901710D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO901710A 1988-08-19 1990-04-18 Syre-resistent fgf-sammensetning og fremgangsmaate for behandling av saardannende sykdommer i mave-tarm kanalen NO901710D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23496688A 1988-08-19 1988-08-19
US07/382,263 US5175147A (en) 1988-08-19 1989-07-20 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
PCT/US1989/003467 WO1990001941A1 (en) 1988-08-19 1989-08-11 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract

Publications (2)

Publication Number Publication Date
NO901710L true NO901710L (no) 1990-04-18
NO901710D0 NO901710D0 (no) 1990-04-18

Family

ID=26928432

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901710A NO901710D0 (no) 1988-08-19 1990-04-18 Syre-resistent fgf-sammensetning og fremgangsmaate for behandling av saardannende sykdommer i mave-tarm kanalen

Country Status (16)

Country Link
US (2) US5175147A (no)
EP (1) EP0360006B1 (no)
JP (1) JP2501480B2 (no)
KR (1) KR920700040A (no)
CN (1) CN1040741A (no)
AT (1) ATE91628T1 (no)
CA (1) CA1330757C (no)
DE (1) DE68907679T2 (no)
DK (1) DK93890D0 (no)
ES (1) ES2058423T3 (no)
FI (2) FI901949A0 (no)
HU (1) HU207227B (no)
IE (1) IE63046B1 (no)
IL (1) IL91322A (no)
NO (1) NO901710D0 (no)
WO (1) WO1990001941A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
JPH0343088A (ja) * 1989-09-29 1991-02-25 Takeda Chem Ind Ltd ａＦＧＦ蛋白質の製造法
EP0406738A3 (en) * 1989-07-03 1991-08-14 Takeda Chemical Industries, Ltd. Production of acidic fgf protein
CA2020720A1 (en) * 1989-07-13 1991-01-14 Shigeko Yamazaki Method for the purification of therapeutically active recombinant acidic fibroblast growth factor
AUPN271295A0 (en) 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
US5972884A (en) * 1991-03-11 1999-10-26 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5739107A (en) 1991-03-11 1998-04-14 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
WO1992018153A1 (en) * 1991-04-12 1992-10-29 Creative Biomolecules, Inc. Method of treating gastrointestinal ulcers with platelet derived growth factor
NO921495L (no) * 1991-04-16 1992-10-19 Seikagaku Kogyo Co Ltd Oligosakkarid og fremgangsmaate for dets fremstilling
US6190864B1 (en) 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
US5348941A (en) * 1992-04-01 1994-09-20 Merck & Co., Inc. Stabilizers for fibroblast growth factors
US5916772A (en) * 1992-06-16 1999-06-29 Whittier Institute For Diabetes And Endocrinology Recombinant production of saporin-containing proteins
US5464815A (en) * 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
FR2718023B1 (fr) * 1994-03-30 1996-08-14 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement de lésions du tractus digestif.
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
US5531880A (en) * 1994-09-13 1996-07-02 Microelectronics And Computer Technology Corporation Method for producing thin, uniform powder phosphor for display screens
FR2724665B1 (fr) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes, plasmides et cellules modifiees
US5593696A (en) * 1994-11-21 1997-01-14 Mcneil-Ppc, Inc. Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
JP2004528005A (ja) * 2000-08-15 2004-09-16 ファージ バイオテクノロジー コーポレイション 生物学的に活性なタンパク質およびペプチドのファージ依存性超産生
AU2001286996A1 (en) * 2000-08-31 2002-03-13 Chiron Corporation Stabilized fgf formulations containing reducing agents
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
EP3752174A4 (en) * 2018-02-13 2021-11-17 University of Florida Research Foundation, Incorporated ANALOGUES OF FIBROBLASTS GROWTH FACTOR AND THEIR USES

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296100A (en) * 1980-06-30 1981-10-20 Franco Wayne P Method of treating the heart for myocardial infarction
EP0105014B1 (en) * 1982-09-24 1992-05-20 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Repair of tissue in animals
JPS6034997A (ja) * 1983-05-09 1985-02-22 ジヨージ、ジヨセフ、トダロ 生物学的活性ポリペプチド類
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
US4745098A (en) * 1984-02-24 1988-05-17 The Regents Of The University Of California Compositions and method for improving wound healing
CA1207239A (en) * 1984-08-10 1986-07-08 Upendra K. Banik Gastrointestinal compositions
JPS6172947A (ja) * 1984-09-18 1986-04-15 Takasago Thermal Eng Co Ltd クリ−ンル−ムの形成法およびこの方法に使用する空気調和設備ユニツト
EP0248819B2 (en) * 1985-09-12 2000-08-30 Scios Inc. Recombinant fibroblast growth factors
WO1989000198A1 (en) * 1987-07-07 1989-01-12 Biotechnology Research Associates, J.V. Recombinant fibroblast growth factors
DK122687A (da) * 1986-03-14 1987-09-15 Takeda Chemical Industries Ltd Polypeptid, dna og anvendelse deraf
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
NZ220917A (en) * 1986-07-11 1991-05-28 Merck & Co Inc Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
JPH01501840A (ja) * 1987-01-16 1989-06-29 アムジエン・インコーポレーテツド 繊維芽細胞成長因子の産生
JPH02504468A (ja) * 1987-11-24 1990-12-20 アムジエン・インコーポレーテツド 繊維芽細胞成長因子のアナログ
AU614137B2 (en) * 1988-06-06 1991-08-22 Takeda Chemical Industries Ltd. Stabilized fgf composition and production thereof
JPH0240399A (ja) * 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物

Also Published As

Publication number Publication date
AU630111B2 (en) 1992-10-22
IE892664L (en) 1990-02-19
FI943028L (fi) 1994-06-22
ATE91628T1 (de) 1993-08-15
HU207227B (en) 1993-03-29
FI943028A7 (fi) 1994-06-22
FI901949A7 (fi) 1990-04-18
IL91322A (en) 1994-12-29
US5175147A (en) 1992-12-29
CN1040741A (zh) 1990-03-28
KR920700040A (ko) 1992-02-19
EP0360006A2 (en) 1990-03-28
CA1330757C (en) 1994-07-19
NO901710D0 (no) 1990-04-18
DK93890A (da) 1990-04-17
EP0360006B1 (en) 1993-07-21
IE63046B1 (en) 1995-03-22
HUT55638A (en) 1991-06-28
IL91322A0 (en) 1990-03-19
DK93890D0 (da) 1990-04-17
DE68907679D1 (de) 1993-08-26
ES2058423T3 (es) 1994-11-01
DE68907679T2 (de) 1994-01-27
FI901949A0 (fi) 1990-04-18
HU895785D0 (en) 1990-12-28
AU4218989A (en) 1990-03-23
US5401721A (en) 1995-03-28
JPH03505736A (ja) 1991-12-12
EP0360006A3 (en) 1990-04-04
FI943028A0 (fi) 1994-06-22
WO1990001941A1 (en) 1990-03-08
JP2501480B2 (ja) 1996-05-29

Similar Documents

Publication Publication Date Title
NO901710D0 (no) Syre-resistent fgf-sammensetning og fremgangsmaate for behandling av saardannende sykdommer i mave-tarm kanalen
ATE406176T1 (de) Il-1-inhibitor in kombinationstherapie zur behandlung il-1-vermittelter krankheiten
NO890224L (no) Fremgangsmaate og anordning for medisinsk behandling av den patologiske tilstand av ben.
NO894296L (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
EP0493362A3 (en) Compositions and kits for the treatment of oral diseases
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
FI830958A7 (fi) Koostumuksia terapeuttista tai diagnostista käyttöä varten ja terapeuttinen käsittelymenetelmä.
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
FI900052A7 (fi) Koostumuksia ja hoitomenetelmiä peräpukamia ja muita varten
DE3878313D1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
FI830959A7 (fi) Koostumuksia terapeuttista tai diagnotista käyttöä varten ja terapeuttinen käsittelymenetelmä.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
UA15913A (uk) Засіб для лікуваhhя запальhих захворюваhь стравоходу та запальhих виразкових захворювань шлуhково-кишкового тракту
NO830527L (no) Analogifremgangsmaate for fremstilling av 2,3-diaryl-5-halogenthiofener
DE3851971D1 (de) Verwendung antigener Substanzen zur Prophylaxe oder Therapie von Störungen und Krankheiten im Verdauungstrakt von Tieren und Menschen.
AU3709289A (en) Strontium salt
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
EP0200214A3 (en) Treatment of parasitic diseases
NO884635L (no) Fremgangsmaate for behandling av voerter.
RU92009328A (ru) Устройство для электротерапии
IL66699A0 (en) Method for diagnosing and for the therapeutic treatment of tumors and/or infections diseases of different types with alkaloidcompounds
IT8741690A0 (it) Farmaco per la profilassi e per la cura delle disbatteriosi vaginali.